Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Age: Adult
Dose: Tablet by mouth – 25 mg
Frequency: once daily at bedtime
Note: Recommended Dose. The decision of dose increase has to be balanced with a higher risk of transaminases elevation.
Age: Adult
Dose: Tablet by mouth – 25-50 mg
Frequency: at bedtime
Note: Any dose increase to 50 mg should be made on an individual patient benefit/risk basis and with strict respect of liver function test (LFT) monitoring.

Child Dose

Clinical InformationAdministration Information
Age: Child
Dose: Not applicable – Not applicable
Note: No approved pediatric dosage available

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment with severe impairment
Dose: Not specified
Note: No relevant modification in agomelatine pharmacokinetic parameters observed;
Condition: Moderate to severe impairment
Dose: Not specified
Note: Caution in moderate to severe impairment.
Administration
  • Take at bedtime
  • Can be taken with or without food
Side Effect

Drug Interaction

Drug NameRisk Factors
CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin)
Increased or decreased bioavailability
Oestrogens
May affect bioavailability

Disease Interaction

Disease NameRisk Factors
Hepatic Impairment
Risk of liver damage

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool and dry place away from light. Keep out of the reach of children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.